1. Home
  2. ABVX vs RUSHB Comparison

ABVX vs RUSHB Comparison

Compare ABVX & RUSHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • RUSHB
  • Stock Information
  • Founded
  • ABVX 2013
  • RUSHB 1965
  • Country
  • ABVX France
  • RUSHB United States
  • Employees
  • ABVX N/A
  • RUSHB N/A
  • Industry
  • ABVX
  • RUSHB Retail-Auto Dealers and Gas Stations
  • Sector
  • ABVX
  • RUSHB Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • RUSHB Nasdaq
  • Market Cap
  • ABVX 5.3B
  • RUSHB 4.2B
  • IPO Year
  • ABVX N/A
  • RUSHB 1996
  • Fundamental
  • Price
  • ABVX $84.01
  • RUSHB $57.82
  • Analyst Decision
  • ABVX Strong Buy
  • RUSHB
  • Analyst Count
  • ABVX 8
  • RUSHB 0
  • Target Price
  • ABVX $90.63
  • RUSHB N/A
  • AVG Volume (30 Days)
  • ABVX 1.2M
  • RUSHB 42.7K
  • Earning Date
  • ABVX 08-11-2025
  • RUSHB 10-28-2025
  • Dividend Yield
  • ABVX N/A
  • RUSHB 1.25%
  • EPS Growth
  • ABVX N/A
  • RUSHB N/A
  • EPS
  • ABVX N/A
  • RUSHB 3.51
  • Revenue
  • ABVX $7,073,400.00
  • RUSHB $7,687,256,000.00
  • Revenue This Year
  • ABVX $25.23
  • RUSHB N/A
  • Revenue Next Year
  • ABVX N/A
  • RUSHB $9.71
  • P/E Ratio
  • ABVX N/A
  • RUSHB $15.73
  • Revenue Growth
  • ABVX N/A
  • RUSHB N/A
  • 52 Week Low
  • ABVX $4.77
  • RUSHB $43.81
  • 52 Week High
  • ABVX $92.91
  • RUSHB $61.55
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 67.94
  • RUSHB 51.79
  • Support Level
  • ABVX $82.72
  • RUSHB $56.23
  • Resistance Level
  • ABVX $91.30
  • RUSHB $59.26
  • Average True Range (ATR)
  • ABVX 3.62
  • RUSHB 1.20
  • MACD
  • ABVX -1.13
  • RUSHB -0.18
  • Stochastic Oscillator
  • ABVX 47.89
  • RUSHB 42.29

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

Share on Social Networks: